Health Care & Life Sciences » Pharmaceuticals | Tianjin Zhongxin Pharmaceutical Group Corp. Ltd.

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
360,589.10
379,436.60
457,868.10
408,786.30
473,260.60
567,787.80
Depreciation, Depletion & Amortization
88,620.90
88,841.20
75,723.10
76,178.20
77,896.60
80,285
Other Funds
74,010.30
79,030.20
808,777.60
9,746.70
71,061.20
10,477.10
Funds from Operations
566,145.10
512,889.80
471,060.10
496,756.20
510,113.70
641,217.70
Changes in Working Capital
174,762.50
152,430.50
115,086.80
58,027.80
377,475.80
126,324
Net Operating Cash Flow
391,382.60
360,459.30
355,973.30
554,784.00
132,637.90
514,893.70
Capital Expenditures
72,422.10
70,151.30
92,640.70
118,172.00
114,419.90
Sale of Fixed Assets & Businesses
530.40
310.70
112.30
18,021.60
587.70
Purchase/Sale of Investments
2,883,495.50
98,222.60
364,616.00
44,281.10
174,626.60
Net Investing Cash Flow
344,164.20
28,381.90
457,144.50
50,449.70
60,794.40
Cash Dividends Paid - Total
73,930.90
36,965.40
110,395.80
192,218.30
115,331.00
Issuance/Reduction of Debt, Net
414,408.50
375,003.80
391,313.70
137,445.60
25,035.20
Net Financing Cash Flow
266,467.40
490,999.50
307,068.10
339,410.60
161,356.90
Net Change in Cash
314,564.80
102,157.50
205,896.80
164,923.80
32,075.30
Free Cash Flow
318,960.60
290,308.00
263,332.60
436,612.10
18,218.00
Deferred Taxes & Investment Tax Credit
1,386.90
3,303.40
5,936.60
5,523.10
17,920.00
17,332.30
Other Sources
-
-
-
9,198.80
-
Exchange Rate Effect
879.00
0.80
-
-
-
Other Uses
3,155,768.10
-
-
3,779.30
-

About Tianjin Zhongxin Pharmaceutical Group Corp.

View Profile
Address
Zhongxin Building
Tianjin Tianjin 300193
China
Employees -
Website -
Updated 07/08/2019
Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.